摘要
目的研究莫西沙星联合盐酸氨溴索对慢性支气管炎的治疗效果。方法研究2015年1~10月慢性支气管炎患者66例,依照数字法分组。采用常规疗法者33例,进入对照组;采用莫西沙星联合盐酸氨溴索者33例,进入实验组。组间比较。结果两组中实验组的咳痰、咳嗽及喘息消失时间更短,住院日更短,治疗有效率更高,差异有统计学意义（P〈0.05）。结论莫西沙星联合盐酸氨溴索治疗慢性支气管炎效果较佳。
Objective Moxifloxacin combined with ambroxol hydrochloride effect in treatment of chronic bronchitis is to be studied. Methods Chose 66 patients of chronic bronchitis who were treated in hospital from January 2015 to October 2015 and separated them into two groups according to digits. 33 patients in control group were given conventional treatment,while another 33 patients in study group were given moxifloxacin combined with ambroxol hydrochloride treatment and then compared treatment effects between two groups. Results Patients’ symptoms disappeared time of sputum,cough and wheezing is shorter and treatment efficacy was higher in study group compared to counterparts in control group,there was a differential between two groups and such a differential has statistic value（P 〈 0.05）. Conclusion Moxifloxacin combined with ambroxol Hydrochloride is quite effective in treatment of chronic bronchitis.
出处
《中国卫生标准管理》
2016年第7期77-78,共2页
China Health Standard Management
关键词
慢性支气管炎
莫西沙星
盐酸氨溴索
治疗
Chronic bronchitis
Moxifloxacin
Ambroxol hydrochloride
Treatment
